Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some Prices

Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some Prices

Today's biggest winners and losers in the stock market.


On this episode of Stock Movers:
- Pfizer (PFE) reported revenue for the fourth quarter that beat the average analyst estimate.
- Merck (MRK) forecast 2026 sales and profit that missed Wall Street’s expectations as continued challenges with its HPV vaccine Gardasil, which may remain off the market in China this year, overshadowed growth from newer drugs. Full-year sales will be $65.5 billion to $67 billion, Merck said Tuesday, below the average estimate from analysts. The company expects adjusted earnings of as much as $5.15 a share. The stock fell as much as 3.2% in pre-market trading.
- Snacks and beverage company PepsiCo (PEP) reported better-than-expected fourth-quarter profit, buoyed by strong international demand, and announced a $10 billion share buyback.New York-based PepsiCo, which owns brands such as Lay’s and Gatorade, posted earnings per share of $2.26, slightly ahead of Wall Street estimates.

See omnystudio.com/listener for privacy information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(2240)

Closing Bell: Marvell Surges on Nvidia Deal, Delta Rises, McCormick Sinks

Closing Bell: Marvell Surges on Nvidia Deal, Delta Rises, McCormick Sinks

On this episode of Stock Movers:Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greif...

31 Mar 5min

Constellation Energy Drops, Marvell Rallies on Nvidia Investment, Unilever Slides

Constellation Energy Drops, Marvell Rallies on Nvidia Investment, Unilever Slides

Today's biggest winners and losers in the stock market.On this episode of Stock Movers: - Constellation Energy (CEG) shares fell as much as 9.3% after it gave an full-year earnings per share guidance ...

31 Mar 4min

Constellation Energy Falls, McCormick Slides, Apellis Pharmaceuticals Gains

Constellation Energy Falls, McCormick Slides, Apellis Pharmaceuticals Gains

On this episode of Stock Movers:- Constellation Energy (CEG) shares fall after it gave an full-year earnings per share guidance that missed the average analyst estimate at the midpoint.- McCormick (MK...

31 Mar 2min

 Eli Lilly Gains, McCormick Rises, Allbirds Soars on American Exchange Deal

Eli Lilly Gains, McCormick Rises, Allbirds Soars on American Exchange Deal

On this episode of Stock Movers:- Eli Lilly (LLY) shares gained. The company agreed to buy sleep drug maker Centessa Pharmaceuticals Plc in a deal worth up to $7.8 billion, a sign the weight-loss medi...

31 Mar 3min

Biogen to Buy Apellis; Lilly to Buy Sleep Drug Maker; Nvidia Invests $2 Billion in Marvell

Biogen to Buy Apellis; Lilly to Buy Sleep Drug Maker; Nvidia Invests $2 Billion in Marvell

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Biogen (BIIB) has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, expanding its treatments i...

31 Mar 3min

Lilly to Buy Centessa Pharmaceuticals; Biogen to Buy Apellis; Unilever Foods Exit

Lilly to Buy Centessa Pharmaceuticals; Biogen to Buy Apellis; Unilever Foods Exit

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Lilly (LLY) to buy Centessa Pharmaceuticals for $38/share in cash plus one non-transferrable contingent value r...

31 Mar 4min

LVMH Falls, Future Slumps, Dermapharm Drops

LVMH Falls, Future Slumps, Dermapharm Drops

On this episode of Stock Movers:- LVMH, SAP, and Novo Nordisk have slumped by about 30% so far this year, making up about 53% of the total market capitalization shed by constituents of the Stoxx Europ...

31 Mar 4min

LVMH Falls, Future Slumps, Getlink Rises

LVMH Falls, Future Slumps, Getlink Rises

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- LVMH, SAP, and Novo Nordisk have slumped by about 30% so far this year, making up about 53% of the total market...

31 Mar 4min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
aftenpodden-usa
stopp-verden
forklart
popradet
fotballpodden-2
det-store-bildet
lydartikler-fra-aftenposten
nokon-ma-ga
dine-penger-pengeradet
rss-gukild-johaug
hanna-de-heldige
rss-espen-lee-usensurert
rss-ness
aftenbla-bla
rss-dannet-uten-piano
grasoner-den-nye-kalde-krigen
e24-podden
frokostshowet-pa-p5